Skip to main content
Linda Resar, MD, Pediatric Hematology & Oncology, Baltimore, MD

Linda Marie Smi Resar MD


Physician

Join to View Full Profile
  • 601 North Caroline StreetBaltimore, MD 21287

  • Phone+1 410-955-3142

  • Fax+1 410-614-8601

Dr. Resar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1989 - 1992
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1986 - 1989
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1986

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1989 - 2025
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN
    Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational Burden
    Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL
    Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Scientists Identify Epigenetic Key That 'Opens' Door to Colon Cancer
    Scientists Identify Epigenetic Key That 'Opens' Door to Colon CancerFebruary 20th, 2025
  • Study Discover Novel Cell Signaling Pathway for Deadly Pancreatic Cancers
    Study Discover Novel Cell Signaling Pathway for Deadly Pancreatic CancersApril 25th, 2023
  • Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate Cures
    Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate CuresMay 9th, 2021
  • Join now to see all

Grant Support

  • Targeting HMGA1 Tumor-Stromal Networks in Pancreatic CarcinogenesisJOHNS HOPKINS UNIVERSITY2024–2029
  • Clonal Hematopoiesis in Healthy Individuals from Families with Early OnsetCoronary Artery DiseaseJOHNS HOPKINS UNIVERSITY2019–2025
  • High Mobility Group A1 Chromatin Regulators in Colon CarcinogenesisJOHNS HOPKINS UNIVERSITY2018–2025
  • High Mobility Group A1 Chromatin Regulators in Colon CarcinogenesisJOHNS HOPKINS UNIVERSITY2018–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: